These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29916102)

  • 1. Associations of serum glucagon levels with glycemic variability in type 1 diabetes with different disease durations.
    Li K; Song WJ; Wu X; Gu DY; Zang P; Gu P; Lu B; Shao JQ
    Endocrine; 2018 Sep; 61(3):473-481. PubMed ID: 29916102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between time in range, a novel measurement of glycemic control and islet secretory function in chinese patients with type 2 diabetes mellitus-An observational study.
    Xu SY; KeLi ; Zhang Z; Liu CY; Guo QY; Lu B; Gu P; Shao JQ
    Diabetes Res Clin Pract; 2021 Mar; 173():108684. PubMed ID: 33539867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between glucose variability evaluated by continuous glucose monitoring and clinical factors, including glucagon-stimulated insulin secretion in patients with type 2 diabetes.
    Ohara M; Hiromura M; Nagaike H; Kohata Y; Fujikawa T; Goto S; Sato N; Kushima H; Terasaki M; Yamamoto T; Mori Y; Hayashi T; Fukui T; Yamagishi SI; Hirano T
    Diabetes Res Clin Pract; 2019 Dec; 158():107904. PubMed ID: 31672500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM.
    Zenz S; Mader JK; Regittnig W; Brunner M; Korsatko S; Boulgaropoulos B; Magnes C; Raml R; Narath SH; Eller P; Augustin T; Pieber TR
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1408-1417. PubMed ID: 29408994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coefficient of variation of R-R interval closely correlates with glycemic variability assessed by continuous glucose monitoring in insulin-depleted patients with type 1 diabetes.
    Iwasaki S; Kozawa J; Fukui K; Iwahashi H; Imagawa A; Shimomura I
    Diabetes Res Clin Pract; 2015 Aug; 109(2):397-403. PubMed ID: 26047681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of beta-glucan supplementation on glycemic control and variability in adolescents with type 1 diabetes mellitus.
    Bozbulut R; Şanlıer N; Döğer E; Bideci A; Çamurdan O; Cinaz P
    Diabetes Res Clin Pract; 2020 Nov; 169():108464. PubMed ID: 32971156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The characteristics of blood glucose fluctuations in patients with fulminant type 1 diabetes mellitus in the stable stage.
    Wang J; Liu BL; Li Z; Li HQ; Sun R; Hu Y; Lee KO; Ye L; Su XF; Ma JH
    Arch Endocrinol Metab; 2018; 62(6):585-590. PubMed ID: 30624497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of type I diabetes affects glucagon and glucose responses to insulin-induced hypoglycemia.
    Lorenzi M; Bohannon N; Tsalikian E; Karam JH
    West J Med; 1984 Oct; 141(4):467-71. PubMed ID: 6390972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
    Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
    Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of morning fasting blood glucose variability with insulin antibodies and clinical factors in type 1 diabetes.
    Yoneda C; Tashima-Horie K; Fukushima S; Saito S; Tanaka S; Haruki T; Ogino J; Suzuki Y; Hashimoto N
    Endocr J; 2016 Jul; 63(7):603-9. PubMed ID: 27170092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between fasting glycemia, serum peptide C, insulin, growth hormone and plasma glucagon in acromegaly].
    Piniewska-Hułas D; Lewandowski Z; Kasperska-Dworak A; Bonicki W
    Pol Arch Med Wewn; 1996 Jun; 95(6):524-33. PubMed ID: 9005421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects.
    Paty BW; Senior PA; Lakey JR; Shapiro AM; Ryan EA
    Diabetes Technol Ther; 2006 Apr; 8(2):165-73. PubMed ID: 16734547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measures of Glycemic Variability in Type 1 Diabetes and the Effect of Real-Time Continuous Glucose Monitoring.
    El-Laboudi AH; Godsland IF; Johnston DG; Oliver NS
    Diabetes Technol Ther; 2016 Dec; 18(12):806-812. PubMed ID: 27996321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of long-term treatment effect in a type 1 diabetes intervention trial: differences after stimulation with glucagon or a mixed meal.
    Pozzilli P; Raz I; Peled D; Elias D; Avron A; Tamir M; Eren R; Dagan S; Cohen IR
    Diabetes Care; 2014; 37(5):1384-91. PubMed ID: 24408401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
    Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
    Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocturnal blood glucose control in type I diabetes mellitus.
    Bolli GB; Perriello G; Fanelli CG; De Feo P
    Diabetes Care; 1993 Dec; 16 Suppl 3():71-89. PubMed ID: 8299480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring.
    Uemura F; Okada Y; Torimoto K; Tanaka Y
    Diabetes Technol Ther; 2018 Feb; 20(2):140-146. PubMed ID: 29293363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood glucose, C-peptide and glucagon levels in patients with a labile course of diabetes mellitus during use of the device "Biostator"].
    Spesivtseva VG; Turova EA; Mamaeva GG; Sotnikova TI
    Probl Endokrinol (Mosk); 1985; 31(5):63-7. PubMed ID: 4070196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.